ABBOTT PARK, Ill., Nov. 13, 2019 /PRNewswire/ -- Abbott (NYSE: ABT) today announced that Miles D. White will be stepping down as Chief Executive Officer on March 31, 2020, after a remarkable 21-year tenure, the second longest for a non-founder in today's S&P 100. He will remain Executive Chairman of the Board. The Board has unanimousl

BOSTON, Nov. 13, 2019 /PRNewswire/ -- Chilmark Research's inaugural Healthcare Payer Ana

SOUTH SAN FRANCISCO, Calif., Nov. 13, 2019 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that Dean Schorno, the company's chief financial officer, is scheduled to present a company overview at the Jefferies 2019 London Healthcare Conference on Thursday, November 21, 2019 at

CRANBURY, N.J., Nov. 13, 2019 /PRNewswire/ -- Palatin Technologies, Inc. (NYSE American: PTN), a specialized biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin and natriuretic peptide receptor systems, whose product candidates are targeted, receptor-specific therapeutics for the treatment of dis

HOUSTON, Nov. 13, 2019 /PRNewswire/ -- Moleculin Biotech, Inc., (Nasdaq: MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company with a broad portfolio of drug candidates targeting highly resistant tumors, announced it has begun preclinical testing of its drug candidate, WP1122, which it believes may present a new approach to treating highly gl

WESTON, Fla., Nov. 13, 2019 /PRNewswire/ -- ZyVersa Therapeutics, Inc. (ZyVersa),  a clinical stage specialty biopharmaceutical company developing first-in-class drugs for treatment of inflammatory and renal diseases, is pleased to announce that Stephen C. Glover, ZyVersa's Co-Founder, Chief Executive Officer, and President, is an

AUSTIN, Texas, Nov. 13, 2019 /PRNewswire/ -- The Refuge for DMST™ (Domestic Minor Sex Trafficking) is collaborating with the Department of Psychiatry at Dell Medical School at The University of Texas at Austin to help improve the lives of young people recovering from sex trafficking by providing care at The Refuge Ranch -- the largest lo

VANCOUVER and SAN DIEGO, CA, Nov. 13, 2019 /PRNewswire/ - Phivida Holdings Inc. (CSE: VIDA; OTC: PHVAF) ("Phivida"), is pleased to announce that it has signed an agreement with an independent distributor to handle sales, merchandising and distribution in Florida for its line of Oki beverag

REDWOOD CITY, Calif., Nov. 13, 2019 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (NASDAQ: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings, today announced a publication analyzing pooled dosing and efficacy data from use of the sufentanil sublingual tablet (SST) 30

NEWARK, Calif., Nov. 13, 2019 /PRNewswire/ -- Protagonist Therapeutics, Inc. (Nasdaq:PTGX) today announced that Dinesh V. Patel, Ph.D., President and Chief Executive Officer, will present at two upcoming healthcare investor conferences in New York.Presentation details:Event: Stife